- Global Pharma News & Resources

Astellas Pharma, Inc Company Profile & Facts –

Pune, Maharashtra, India, October 10 2022 (Wiredrelease) Prudour Pvt. Ltd –:Astellas Pharma, Inc. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. The company was founded in April of 1953 and has since become one of the largest pharmaceutical companies in Japan. Astellas Pharma’s main focus is on the research and development of new drugs and treatments for various diseases and conditions. The company also manufactures and markets over-the-counter medications, medical devices, and health supplements. Astellas Pharma employs over 17,000 people worldwide and has operations in more than 50 countries. In 2015, the company generated sales of over ¥1 trillion (US$8.3 billion). Astellas Pharma is a member of the Nikkei 225 stock index and is listed on the Tokyo Stock Exchange. Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, Revenue (US$ Mn), Operating Income (US$ Mn), Net Income (US$ Mn), SWOT Analysis, detailed reports on mergers and acquisitions (M&A), divestments, capital raising, venture capital investments, ownership and partnership transactions undertaken by Astellas Pharma, Inc Company – Mergers & Acquisitions (M&A), Partnerships & Alliances 

Key Financials
Revenue (US$ Mn)

US$ 11,257 Mn was the annual revenue generated by Astellas Pharma, Inc. in 2021

Astellas Pharma, Inc.’s annual revenue for 2020 was US$ 11,583 Mn, a -1.28% decrease from 2019

From 2018’s annual revenues, Astellas Pharma, Inc. registered a -4.55% decrease in 2019, amounting to US$ 11,734 Mn

Total revenue of US$ 12,293 Mn was generated in 2018 by Astellas Pharma, Inc.

Buy this Complete Company Profile-

Key Highlights

This report includes Astellas Pharma, Inc Company – Mergers & Acquisitions (M&A), Partnerships & Alliance’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Astellas Pharma, Inc Company – Mergers & Acquisitions (M&A), Partnerships & Alliances. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to buy

– Access comprehensive financial deals data along with charts and graphs covering M&A, private equity, and partnerships and alliances.

– Form an independent opinion about Astellas Pharma, Inc Company – Mergers & Acquisitions (M&A), Partnerships & Alliances’s growth strategies through the organic and inorganic activities.

– Track your competitor’s business structure and growth strategies.

To get exclusive information-

Table of Contents



Mergers and Acquisitions – Deal reports


Corporate Venturing – Deal reports


Partnership – Deal reports


Capital Raising – Overview

Capital Raising – Deal reports

Divestments – Deal reports

Related Report Insights:

Global Anti-Infective Agents Market:

Global Histoplasmosis Treatment Market:

Global Organ Transplant Immunosuppressant Drugs Market:

Global Drug Repurposing Market:

Global Cardiovascular Drugs Market:

Global Pertussis Vaccine Market:

Global Ibuprofen Market:

This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 10-Oct-2022